\BOOKMARK [1][-]{section.1}{Background}{}% 1
\BOOKMARK [1][-]{section.2}{Results}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{XPRESSpipe}{section.2}% 3
\BOOKMARK [3][-]{subsubsection.2.1.1}{Inputs}{subsection.2.1}% 4
\BOOKMARK [3][-]{subsubsection.2.1.2}{Automated Reference Curation}{subsection.2.1}% 5
\BOOKMARK [3][-]{subsubsection.2.1.3}{GTF Modification}{subsection.2.1}% 6
\BOOKMARK [3][-]{subsubsection.2.1.4}{Read Processing}{subsection.2.1}% 7
\BOOKMARK [3][-]{subsubsection.2.1.5}{Trimming}{subsection.2.1}% 8
\BOOKMARK [3][-]{subsubsection.2.1.6}{Alignment}{subsection.2.1}% 9
\BOOKMARK [3][-]{subsubsection.2.1.7}{Post-alignment Processing}{subsection.2.1}% 10
\BOOKMARK [3][-]{subsubsection.2.1.8}{Read Quantification}{subsection.2.1}% 11
\BOOKMARK [3][-]{subsubsection.2.1.9}{Normalization}{subsection.2.1}% 12
\BOOKMARK [3][-]{subsubsection.2.1.10}{Quality Control}{subsection.2.1}% 13
\BOOKMARK [3][-]{subsubsection.2.1.11}{Read Length Distribution}{subsection.2.1}% 14
\BOOKMARK [3][-]{subsubsection.2.1.12}{Library Complexity}{subsection.2.1}% 15
\BOOKMARK [3][-]{subsubsection.2.1.13}{Metagene Estimation Profile}{subsection.2.1}% 16
\BOOKMARK [3][-]{subsubsection.2.1.14}{Gene Coverage Profile}{subsection.2.1}% 17
\BOOKMARK [3][-]{subsubsection.2.1.15}{Codon Phasing/Periodicity Estimation Profile}{subsection.2.1}% 18
\BOOKMARK [3][-]{subsubsection.2.1.16}{rRNA Depletion Probe}{subsection.2.1}% 19
\BOOKMARK [3][-]{subsubsection.2.1.17}{Differential Expression Analysis}{subsection.2.1}% 20
\BOOKMARK [3][-]{subsubsection.2.1.18}{Outputs}{subsection.2.1}% 21
\BOOKMARK [2][-]{subsection.2.2}{XPRESSplot}{section.2}% 22
\BOOKMARK [3][-]{subsubsection.2.2.1}{Input Data}{subsection.2.2}% 23
\BOOKMARK [3][-]{subsubsection.2.2.2}{Normalization}{subsection.2.2}% 24
\BOOKMARK [3][-]{subsubsection.2.2.3}{Analyzing Data}{subsection.2.2}% 25
\BOOKMARK [3][-]{subsubsection.2.2.4}{Principal Components Analysis}{subsection.2.2}% 26
\BOOKMARK [3][-]{subsubsection.2.2.5}{Volcano Plot}{subsection.2.2}% 27
\BOOKMARK [2][-]{subsection.2.3}{Validation}{section.2}% 28
\BOOKMARK [3][-]{subsubsection.2.3.1}{New Insights from Published Ribosome Profiling Data}{subsection.2.3}% 29
\BOOKMARK [3][-]{subsubsection.2.3.2}{Performance Validation Using TCGA Data}{subsection.2.3}% 30
\BOOKMARK [3][-]{subsubsection.2.3.3}{Cost Analysis}{subsection.2.3}% 31
\BOOKMARK [1][-]{section.3}{Discussion}{}% 32
\BOOKMARK [1][-]{section.4}{Conclusions}{}% 33
\BOOKMARK [1][-]{section.5}{Materials and Methods}{}% 34
\BOOKMARK [2][-]{subsection.5.1}{Software Dependencies}{section.5}% 35
\BOOKMARK [2][-]{subsection.5.2}{GTF Modification}{section.5}% 36
\BOOKMARK [2][-]{subsection.5.3}{GTF Flattened Record}{section.5}% 37
\BOOKMARK [2][-]{subsection.5.4}{Normalization}{section.5}% 38
\BOOKMARK [2][-]{subsection.5.5}{Quality Control Summary Plotting}{section.5}% 39
\BOOKMARK [2][-]{subsection.5.6}{Metagene Estimation}{section.5}% 40
\BOOKMARK [2][-]{subsection.5.7}{Periodicity}{section.5}% 41
\BOOKMARK [2][-]{subsection.5.8}{rRNA Probe}{section.5}% 42
\BOOKMARK [2][-]{subsection.5.9}{Confidence Interval Plotting}{section.5}% 43
\BOOKMARK [2][-]{subsection.5.10}{Ribosome Profiling Data Analysis}{section.5}% 44
\BOOKMARK [2][-]{subsection.5.11}{TCGA Data Analysis}{section.5}% 45
\BOOKMARK [2][-]{subsection.5.12}{Cost Analysis}{section.5}% 46
